Coloplast revenue and financials
kr 418.80Change from previous close: +2.15%Absolute change: +kr 8.80
In the fiscal year ended September 2024, Coloplast reported revenue of kr 27.03B (+10.33% year over year). Net income was kr 5.05B, a net margin of 18.7%.
Fiscal year ending in September. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +10.33%
- FY to Sep 2024 vs FY to Sep 2023
- Net income growth
- +5.62%
- FY to Sep 2024 vs FY to Sep 2023
- Net margin
- 18.7%
- FY to Sep 2023: 19.5%
Financial data
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | FY to Sep 2024 | FY to Sep 2023 | FY to Sep 2022 |
|---|---|---|---|
| Operating cash flow | 2,766 | 4,226 | 5,099 |
| Depreciation and amortization | 1,290 | 1,069 | 930 |
| Capital expenditure | -1,346 | -1,241 | -1,135 |
| Investing cash flow | -1,336 | -8,957 | -11,759 |
| Financing cash flow | -1,518 | 5,265 | 6,591 |
| Dividends paid | -4,720 | -4,247 | -4,041 |
| Share repurchases | — | 0.0 | -619 |
| Debt issued | 7,818 | 622 | 16,367 |
| Debt repaid | -4,848 | 0.0 | -5,398 |
| Net change in cash | -88.0 | 534 | -69.0 |
| Free cash flow | 1,420 | 2,985 | 3,964 |